English
简体中文
Total: £ 56.28
Published Date: 2026-04-07 | Pages: 115 | Tables: 111 | Pharma & Healthcare
The global Whooping Cough Preventable Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Whooping Cough Preventable Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Whooping cough preventable vaccine is a vaccine that protects against whooping cough (pertussis). There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
The North American market for Whooping Cough Preventable Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Whooping Cough Preventable Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Whooping Cough Preventable Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Whooping Cough Preventable Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Whooping Cough Preventable Vaccine. The Whooping Cough Preventable Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Whooping Cough Preventable Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Whooping Cough Preventable Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
Acellular Vaccines
Whole-Cell Vaccines
by Application
12 Months Below
12 Months Above
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Whooping Cough Preventable Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Whooping Cough Preventable Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Whooping Cough Preventable Vaccine Market Overview
1.1 Product Definition
1.2 Whooping Cough Preventable Vaccine by Type
1.2.1 Global Whooping Cough Preventable Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Acellular Vaccines
1.2.3 Whole-Cell Vaccines
1.3 Whooping Cough Preventable Vaccine by Application
1.3.1 Global Whooping Cough Preventable Vaccine Market Value by Application: 2025 vs 2032
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global Whooping Cough Preventable Vaccine Market Size Estimates and Forecasts
1.4.1 Global Whooping Cough Preventable Vaccine Revenue 2021–2032
1.4.2 Global Whooping Cough Preventable Vaccine Sales 2021–2032
1.4.3 Global Whooping Cough Preventable Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Whooping Cough Preventable Vaccine Market Competition by Manufacturers
2.1 Global Whooping Cough Preventable Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Whooping Cough Preventable Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Whooping Cough Preventable Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Whooping Cough Preventable Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Whooping Cough Preventable Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Whooping Cough Preventable Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Whooping Cough Preventable Vaccine, Date of Entry into the Industry
2.8 Global Whooping Cough Preventable Vaccine Market Competitive Situation and Trends
2.8.1 Global Whooping Cough Preventable Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Whooping Cough Preventable Vaccine Players Market Share by Revenue
2.8.3 Global Whooping Cough Preventable Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Whooping Cough Preventable Vaccine Market Scenario by Region
3.1 Global Whooping Cough Preventable Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Whooping Cough Preventable Vaccine Sales by Region: 2021–2032
3.2.1 Global Whooping Cough Preventable Vaccine Sales by Region: 2021–2026
3.2.2 Global Whooping Cough Preventable Vaccine Sales by Region: 2027–2032
3.3 Global Whooping Cough Preventable Vaccine Revenue by Region: 2021–2032
3.3.1 Global Whooping Cough Preventable Vaccine Revenue by Region: 2021–2026
3.3.2 Global Whooping Cough Preventable Vaccine Revenue by Region: 2027–2032
3.4 North America Whooping Cough Preventable Vaccine Market Facts & Figures by Country
3.4.1 North America Whooping Cough Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Whooping Cough Preventable Vaccine Sales by Country (2021–2032)
3.4.3 North America Whooping Cough Preventable Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Whooping Cough Preventable Vaccine Market Facts & Figures by Country
3.5.1 Europe Whooping Cough Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Whooping Cough Preventable Vaccine Sales by Country (2021–2032)
3.5.3 Europe Whooping Cough Preventable Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Whooping Cough Preventable Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Whooping Cough Preventable Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Whooping Cough Preventable Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Whooping Cough Preventable Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Whooping Cough Preventable Vaccine Market Facts & Figures by Country
3.7.1 Latin America Whooping Cough Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Whooping Cough Preventable Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Whooping Cough Preventable Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Whooping Cough Preventable Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Whooping Cough Preventable Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Whooping Cough Preventable Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Whooping Cough Preventable Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Whooping Cough Preventable Vaccine Sales by Type (2021–2032)
4.1.1 Global Whooping Cough Preventable Vaccine Sales by Type (2021–2026)
4.1.2 Global Whooping Cough Preventable Vaccine Sales by Type (2027–2032)
4.1.3 Global Whooping Cough Preventable Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Whooping Cough Preventable Vaccine Revenue by Type (2021–2032)
4.2.1 Global Whooping Cough Preventable Vaccine Revenue by Type (2021–2026)
4.2.2 Global Whooping Cough Preventable Vaccine Revenue by Type (2027–2032)
4.2.3 Global Whooping Cough Preventable Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Whooping Cough Preventable Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Whooping Cough Preventable Vaccine Sales by Application (2021–2032)
5.1.1 Global Whooping Cough Preventable Vaccine Sales by Application (2021–2026)
5.1.2 Global Whooping Cough Preventable Vaccine Sales by Application (2027–2032)
5.1.3 Global Whooping Cough Preventable Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Whooping Cough Preventable Vaccine Revenue by Application (2021–2032)
5.2.1 Global Whooping Cough Preventable Vaccine Revenue by Application (2021–2026)
5.2.2 Global Whooping Cough Preventable Vaccine Revenue by Application (2027–2032)
5.2.3 Global Whooping Cough Preventable Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Whooping Cough Preventable Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Whooping Cough Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sanofi Pasteur Whooping Cough Preventable Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Whooping Cough Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Whooping Cough Preventable Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Company Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Whooping Cough Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mitsubishi Tanabe Pharma Whooping Cough Preventable Vaccine Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Company Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics Whooping Cough Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 KM Biologics Whooping Cough Preventable Vaccine Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Company Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products Whooping Cough Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Wuhan Institute of Biological Products Whooping Cough Preventable Vaccine Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Whooping Cough Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Walvax Biotechnology Whooping Cough Preventable Vaccine Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.7.1 Chengdu Institute of Biological Products Company Information
6.7.2 Chengdu Institute of Biological Products Description and Business Overview
6.7.3 Chengdu Institute of Biological Products Whooping Cough Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Chengdu Institute of Biological Products Whooping Cough Preventable Vaccine Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Company Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology Whooping Cough Preventable Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Minhai Biotechnology Whooping Cough Preventable Vaccine Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Whooping Cough Preventable Vaccine Industry Chain Analysis
7.2 Whooping Cough Preventable Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Whooping Cough Preventable Vaccine Production Mode & Process Analysis
7.4 Whooping Cough Preventable Vaccine Sales and Marketing
7.4.1 Whooping Cough Preventable Vaccine Sales Channels
7.4.2 Whooping Cough Preventable Vaccine Distributors
7.5 Whooping Cough Preventable Vaccine Customer Analysis
8 Whooping Cough Preventable Vaccine Market Dynamics
8.1 Whooping Cough Preventable Vaccine Industry Trends
8.2 Whooping Cough Preventable Vaccine Market Drivers
8.3 Whooping Cough Preventable Vaccine Market Challenges
8.4 Whooping Cough Preventable Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Whooping Cough Preventable Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Whooping Cough Preventable Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Whooping Cough Preventable Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Whooping Cough Preventable Vaccine Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Whooping Cough Preventable Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Whooping Cough Preventable Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Whooping Cough Preventable Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Whooping Cough Preventable Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Whooping Cough Preventable Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Whooping Cough Preventable Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Whooping Cough Preventable Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Whooping Cough Preventable Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Whooping Cough Preventable Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Whooping Cough Preventable Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Whooping Cough Preventable Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Whooping Cough Preventable Vaccine Sales by Region (K Dose), 2021–2026
Table 18. Global Whooping Cough Preventable Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Whooping Cough Preventable Vaccine Sales by Region (K Dose), 2027–2032
Table 20. Global Whooping Cough Preventable Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Whooping Cough Preventable Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Whooping Cough Preventable Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Whooping Cough Preventable Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Whooping Cough Preventable Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Whooping Cough Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Whooping Cough Preventable Vaccine Sales by Country (K Dose), 2021–2026
Table 27. North America Whooping Cough Preventable Vaccine Sales by Country (K Dose), 2027–2032
Table 28. North America Whooping Cough Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Whooping Cough Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Whooping Cough Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Whooping Cough Preventable Vaccine Sales by Country (K Dose), 2021–2026
Table 32. Europe Whooping Cough Preventable Vaccine Sales by Country (K Dose), 2027–2032
Table 33. Europe Whooping Cough Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Whooping Cough Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Whooping Cough Preventable Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Whooping Cough Preventable Vaccine Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Whooping Cough Preventable Vaccine Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Whooping Cough Preventable Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Whooping Cough Preventable Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Whooping Cough Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Whooping Cough Preventable Vaccine Sales by Country (K Dose), 2021–2026
Table 42. Latin America Whooping Cough Preventable Vaccine Sales by Country (K Dose), 2027–2032
Table 43. Latin America Whooping Cough Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Whooping Cough Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Whooping Cough Preventable Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Whooping Cough Preventable Vaccine Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Whooping Cough Preventable Vaccine Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Whooping Cough Preventable Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Whooping Cough Preventable Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Whooping Cough Preventable Vaccine Sales (K Dose) by Type (2021–2026)
Table 51. Global Whooping Cough Preventable Vaccine Sales (K Dose) by Type (2027–2032)
Table 52. Global Whooping Cough Preventable Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Whooping Cough Preventable Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Whooping Cough Preventable Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Whooping Cough Preventable Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Whooping Cough Preventable Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Whooping Cough Preventable Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Type (2021–2026)
Table 59. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Type (2027–2032)
Table 60. Global Whooping Cough Preventable Vaccine Sales (K Dose) by Application (2021–2026)
Table 61. Global Whooping Cough Preventable Vaccine Sales (K Dose) by Application (2027–2032)
Table 62. Global Whooping Cough Preventable Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Whooping Cough Preventable Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Whooping Cough Preventable Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Whooping Cough Preventable Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Whooping Cough Preventable Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Whooping Cough Preventable Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Application (2021–2026)
Table 69. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Application (2027–2032)
Table 70. Sanofi Pasteur Company Information
Table 71. Sanofi Pasteur Description and Business Overview
Table 72. Sanofi Pasteur Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Sanofi Pasteur Whooping Cough Preventable Vaccine Product
Table 74. Sanofi Pasteur Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. GSK Whooping Cough Preventable Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Mitsubishi Tanabe Pharma Company Information
Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
Table 82. Mitsubishi Tanabe Pharma Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Mitsubishi Tanabe Pharma Whooping Cough Preventable Vaccine Product
Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 85. KM Biologics Company Information
Table 86. KM Biologics Description and Business Overview
Table 87. KM Biologics Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. KM Biologics Whooping Cough Preventable Vaccine Product
Table 89. KM Biologics Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Company Information
Table 91. Wuhan Institute of Biological Products Description and Business Overview
Table 92. Wuhan Institute of Biological Products Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Wuhan Institute of Biological Products Whooping Cough Preventable Vaccine Product
Table 94. Wuhan Institute of Biological Products Recent Developments/Updates
Table 95. Walvax Biotechnology Company Information
Table 96. Walvax Biotechnology Description and Business Overview
Table 97. Walvax Biotechnology Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Walvax Biotechnology Whooping Cough Preventable Vaccine Product
Table 99. Walvax Biotechnology Recent Developments/Updates
Table 100. Chengdu Institute of Biological Products Company Information
Table 101. Chengdu Institute of Biological Products Description and Business Overview
Table 102. Chengdu Institute of Biological Products Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Chengdu Institute of Biological Products Whooping Cough Preventable Vaccine Product
Table 104. Chengdu Institute of Biological Products Recent Developments/Updates
Table 105. Minhai Biotechnology Company Information
Table 106. Minhai Biotechnology Description and Business Overview
Table 107. Minhai Biotechnology Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Minhai Biotechnology Whooping Cough Preventable Vaccine Product
Table 109. Minhai Biotechnology Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Whooping Cough Preventable Vaccine Distributors List
Table 113. Whooping Cough Preventable Vaccine Customers List
Table 114. Whooping Cough Preventable Vaccine Market Trends
Table 115. Whooping Cough Preventable Vaccine Market Drivers
Table 116. Whooping Cough Preventable Vaccine Market Challenges
Table 117. Whooping Cough Preventable Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Whooping Cough Preventable Vaccine
Figure 2. Global Whooping Cough Preventable Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Whooping Cough Preventable Vaccine Market Share by Type: 2025 & 2032
Figure 4. Acellular Vaccines Product Picture
Figure 5. Whole-Cell Vaccines Product Picture
Figure 6. Global Whooping Cough Preventable Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Whooping Cough Preventable Vaccine Market Share by Application: 2025 & 2032
Figure 8. 12 Months Below
Figure 9. 12 Months Above
Figure 10. Global Whooping Cough Preventable Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Whooping Cough Preventable Vaccine Market Size (US$ Million), 2021–2032
Figure 12. Global Whooping Cough Preventable Vaccine Sales (K Dose), 2021–2032
Figure 13. Global Whooping Cough Preventable Vaccine Average Price (US$/Dose), 2021–2032
Figure 14. Whooping Cough Preventable Vaccine Report Years Considered
Figure 15. Whooping Cough Preventable Vaccine Sales Share by Manufacturers in 2025
Figure 16. Global Whooping Cough Preventable Vaccine Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Whooping Cough Preventable Vaccine Players: Market Share by Revenue in Whooping Cough Preventable Vaccine in 2025
Figure 18. Whooping Cough Preventable Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Whooping Cough Preventable Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Whooping Cough Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 21. North America Whooping Cough Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 22. United States Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Whooping Cough Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 25. Europe Whooping Cough Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 26. Germany Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Whooping Cough Preventable Vaccine Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Whooping Cough Preventable Vaccine Revenue Market Share by Region (2021–2032)
Figure 33. China Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Whooping Cough Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 41. Latin America Whooping Cough Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Whooping Cough Preventable Vaccine Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Whooping Cough Preventable Vaccine Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Whooping Cough Preventable Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Whooping Cough Preventable Vaccine by Type (2021–2032)
Figure 52. Global Revenue Market Share of Whooping Cough Preventable Vaccine by Type (2021–2032)
Figure 53. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Type (2021–2032)
Figure 54. Global Sales Market Share of Whooping Cough Preventable Vaccine by Application (2021–2032)
Figure 55. Global Revenue Market Share of Whooping Cough Preventable Vaccine by Application (2021–2032)
Figure 56. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Application (2021–2032)
Figure 57. Whooping Cough Preventable Vaccine Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
